Body mass index influences the response to infliximab in ankylosing spondylitis (Q36245977)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Body mass index influences the response to infliximab in ankylosing spondylitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

main subject

ankylosing spondylitis

1 reference

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

8

Marine Meunier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

9

Gilles Hayem

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Sébastien Ottaviani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Yannick Allanore

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Florence Tubach

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Marine Forien

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Anaïs Gardette

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Blandine Pasquet

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Elisabeth Palazzo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Chantal Job-Deslandre

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

André Kahan

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Olivier Meyer

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

14 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

Arthritis Research and Therapy

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

R115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1186/ar3841

1 February 2020

exact match

0 references

cites work

Obesity and psoriasis: body weight and body mass index influence the response to biological treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446492

Predicting the outcome of ankylosing spondylitis therapy

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446492

Effect of obesity on the pharmacokinetics of drugs in humans

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446492

Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446492

Metabolic disturbances linked to obesity: the role of impaired tissue perfusion

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446492

Measurement of nutrition status in Crohn's disease patients receiving infliximab therapy

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446492

Adipocytokines: mediators linking adipose tissue, inflammation and immunity

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446492

Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446492

International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446492

Choice of drug treatment for obesity-related hypertension: where is the evidence?

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446492

Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446492

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446492

Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446492

Circulating concentration of infliximab and response to treatment in ankylosing spondylitis: results from a randomized control study.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446492

Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446492

Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446492

Factors affecting the pharmacokinetics of CPT-11: the body mass index, age and sex are independent predictors of pharmacokinetic parameters of CPT-11.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446492

Effects of a 6-month infliximab treatment on plasma levels of leptin and adiponectin in patients with rheumatoid arthritis

22 September 2018

1 reference

12 December 2020

Body mass index and clinical response to infliximab in rheumatoid arthritis

1 reference

12 December 2020

Increases in body mass index during infliximab therapy in patients with Crohn's disease: an open label prospective study

1 reference

12 December 2020

The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor

1 reference

12 December 2020

Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT)

1 reference

12 December 2020

Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis

1 reference

12 December 2020

Rheumatoid arthritis: the multifaceted role of adiponectin in inflammatory joint disease

1 reference

12 December 2020

Identifiers

DOI

10.1186/AR3841

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 February 2020

1050619576

0 references

Fatcat ID

release_6tjlzpqbgvf4df7k7y3ngwmeey

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6tjlzpqbgvf4df7k7y3ngwmeey

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22584116%20AND%20SRC:MED&resulttype=core&format=json